Among significant news in a holiday spattered week, Dutch biotech argenx gained another approval in Japan for its Vyvdura (efgartigimod alfa and hyaluronidase-qvf), this time for adult patients with ...

Alfa Anderson in 1979 - LGI Stock But in 1983 she received a letter, she recalled. “What will be forever emblazoned on my mind was: ‘As of this day, your services will no longer be required.’ I was ...

Dutch immunology specialist argenx announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) approved Vyvdura ...